Staar Surgical Co (STU:SR3) EPS (Basic): €-0.37 (TTM As of Mar. 2026)


STU:SR3 Staar Surgical Co STU:SR3
79 GF Score
Price €27.44
GF Value €27.60
! 7 Warning Signs
View Full Analysis

What is Staar Surgical Co EPS (Basic)?

Staar Surgical Co STU:SR3 +8.50% 79 EPS (Basic) is €-0.37 as of Mar. 2026. GuruFocus rates STU:SR3 with a GF Score™ of 79/100 and a GF Value™ of €27.60. The stock has 7 warning signs investors should review.

Staar Surgical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.09. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.37.

Staar Surgical Co's EPS (Diluted) for the three months ended in Mar. 2026 was €0.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.37.

Staar Surgical Co's EPS without NRI for the three months ended in Mar. 2026 was €0.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Staar Surgical Co's highest 3-Year average EPS without NRI Growth Rate was 227.10% per year. The lowest was -34.10% per year. And the median was 14.30% per year.

Staar Surgical Co  (STU:SR3) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Staar Surgical Co EPS (Basic) Related Terms

Staar Surgical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co EPS (Basic) Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.78 0.40 -0.39 -1.38

Staar Surgical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.02 -0.30 0.15 -0.32 0.09
STU:SR3
79GF Score
Staar Surgical Co STU:SR3
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Staar Surgical Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-68.703-0)/49.568
=-1.39

Staar Surgical Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.503-0)/49.908
=0.09

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-0.37 mean?
Staar Surgical Co (STU:SR3) has a EPS (Basic) of €-0.37 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Staar Surgical Co and its competitors.
Is Staar Surgical Co's EPS (Basic) too high?
Staar Surgical Co's current EPS (Basic) is €-0.37. Overall, Staar Surgical Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's EPS (Basic) compare to NNNN and ATRC?
Staar Surgical Co's EPS (Basic) of €-0.37 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current EPS (Basic) is €-0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Staar Surgical Co (STU:SR3) has a current EPS (Basic) of €-0.37. The stock's GF Value™ is €27.60, compared to a current price of €27.44 — trading 0.6% below its estimated fair value. The current EPS (Basic) is €-0.37. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Staar Surgical Co (STU:SR3), the current EPS (Basic) is €-0.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (STU:SR3) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of €27.44 is trading 0.6% below its estimated GF Value™ of €27.60.

Key valuation signals for STU:SR3:

  • EPS (Basic): €-0.37
  • GF Value™: €27.60 vs. price of €27.44 (0.6% below fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the STU:SR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Staar Surgical Co Business Description

Other Exchanges STAA:USASR3:Germany
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score

Get the complete analysis for STU:SR3

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.44
Price
€27.60
GF Value